Impac Software announced its collaboration with the National Comprehensive Cancer Network (NCCN) to license NCCN’s clinical care content to clinicians utilizing MOSAIQ®, Impac’s oncology electronic medical record (EMR).

MOSAIQ will be the first oncology EMR to embed an intelligent search engine that dynamically links to the NCCN Clinical Practice Guidelines in Oncology™. The NCCN Guidelines are used by clinicians to shape care recommendations covering 97 percent of all patients with cancer and are updated on a continual basis. The NCCN Guidelines, developed through an explicit review of evidence and recommendations from medical experts, address cancer detection, prevention and risk reduction, workup and diagnosis and treatment and supportive care.

In addition, MOSAIQ also will provide active access to the NCCN Drugs & Biologics Compendium™, which delineates uses of drugs and biologics in the care of patients with cancer, listing FDA-approved disease indications as well as off-label recommendations for use, and to the NCCN Chemotherapy Order Templates™.

“NCCN is looking forward to working with Impac Software to provide another important channel for distribution of the NCCN Guidelines,” says William T. McGivney, PhD, NCCN Chief Executive Officer. “As a result, clinicians will be provided with ready access to the best possible treatment options to improve outcomes for all patients with cancer.”

“Simplified, real-time access to NCCN’s evidence-based clinical content is expected to enhance the delivery of standardized care and improve patient safety,” says Joel Goldwein, M.D., Vice President of Medical Affairs for The Elekta Group. “Many of Impac’s customers are NCCN Member Institutions; however simplifying access to NCCN’s clinical content will significantly increase the use of NCCN Guidelines throughout Impac Software’s existing customer base, and in hundreds of cancer care centers.”